nPhase announced a USD 30 million Series D on 2 November 2026, led by Viking Global Investors. The financing is the clinical technology company's first equity raise since 2017. nPhase connects trial and real world data through a governed platform for pharmaceutical sponsors and research organisations. Its software combines data management and statistical computing from study setup through regulatory submission. Chief executive Scott Climes said the capital will scale the enterprise business, expand agentic AI workflows and support international growth. The company did not disclose other investors or a valuation. The amount represents current equity proceeds rather than cumulative funding or a debt facility.
nPhase raises USD 30m Series D
Viking Global Investors backs clinical data platform expansion

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


